학술논문

Is clinical variability in CMT1A related to epigenetic factors?
Document Type
Abstract
Source
Journal of the Peripheral Nervous System. Jun2004, Vol. 9 Issue 2, p111-111. 1p.
Subject
*CHARCOT-Marie-Tooth disease
*SPINAL muscular atrophy
*GENETIC disorders
*MUSCULAR atrophy
*NEUROMUSCULAR diseases
*NEUROLOGICAL disorders
Language
ISSN
1085-9489
Abstract
CMT1A patients bear the same genetic defect but often present with a wide range of clinical disability. Knowing the relationship between the phenotypic variability and other parameters, such as electrophysiological findings, age, gender, disease duration and environmental factors may be important for understanding the pathogenetic mechanisms underlying CMT1A. We studied 15 families and 7 sporadic cases affected by CMT1A (27 adults and 9 children) from the clinical, neurophysiological and genetic standpoint. A detailed patient history included: disease onset and progression, distribution of weakness, additional symptoms, life habits, genealogical tree, exposure to toxic substances, geographic provenance, instruction grade, job, use of drugs, and concurrent diseases. A questionnaire about diet was administered. The disability was evaluated by modified Rankin scale, deambulation index, functional independence measure and Barthel index. As previously reported, disease onset was in the first decade in 50% of cases and before the age of 20 years in 70% of cases. Severe disability was rarely observed, only 2 patients walking with a cane. No clear influence of gender over clinical severity was observed. Interestingly, genetic anticipation was observed in all the families. Data on the influence of environmental factors will also be presented. [ABSTRACT FROM AUTHOR]